These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9296444)

  • 1. European hydroxyethyl starch: a safe and inexpensive alternative to albumin.
    Treib J; Haass A; Schimrigk K
    Anesth Analg; 1997 Sep; 85(3):709. PubMed ID: 9296444
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Outcomes and Medical Costs of Hydration Therapy with Hydroxyethyl Starch (130/0.4) or Acute Single Infarction.
    Fujita A; Matsuzaka M; Metoki N; Hagii J; Shiroto H; Iwata M; Tanaka R; Tsuda E
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105705. PubMed ID: 33711759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis.
    Opperer M; Poeran J; Rasul R; Mazumdar M; Memtsoudis SG
    BMJ; 2015 Mar; 350():h1567. PubMed ID: 25817299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. But is it safe? Hydroxyethyl starch in perioperative care.
    Greenberg S; Tung A
    Anesth Analg; 2015 Mar; 120(3):519-521. PubMed ID: 25695570
    [No Abstract]   [Full Text] [Related]  

  • 5. Colloid solutions in the perioperative setting.
    Haase N; Perner A
    BMJ; 2015 Mar; 350():h1656. PubMed ID: 25817457
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyethyl starch: here today, gone tomorrow.
    Nolan JP; Mythen MG
    Br J Anaesth; 2013 Sep; 111(3):321-4. PubMed ID: 23946354
    [No Abstract]   [Full Text] [Related]  

  • 7. Acid-base changes caused by 5% albumin versus 6% hydroxyethyl starch solution in patients undergoing acute normovolemic hemodilution: a randomized prospective study.
    Rehm M; Orth V; Scheingraber S; Kreimeier U; Brechtelsbauer H; Finsterer U
    Anesthesiology; 2000 Nov; 93(5):1174-83. PubMed ID: 11046202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement fluids in plasmapheresis: cross-over comparative study.
    Le Conte P; Nicolas F; Adjou C; N'Guyen JM; Billaud E; Moreau P
    Intensive Care Med; 1997 Mar; 23(3):342-4. PubMed ID: 9083239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bring rapidly degradable hydroxyethyl starch to the United States.
    Tang JF; Pittet JF; Ganter MT
    Anesthesiology; 2006 May; 104(5):1105-6; author reply 1106. PubMed ID: 16645466
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyethyl starch solutions and patient harm.
    Roberts I; Shakur H; Bellomo R; Bion J; Finfer S; Hunt B; Myburgh J; Perner A; Reinhart K
    Lancet; 2018 Feb; 391(10122):736. PubMed ID: 29449012
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse effects of plasma volume expanders.
    Isbister JP; Fisher MM
    Anaesth Intensive Care; 1980 May; 8(2):145-51. PubMed ID: 6156607
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long-term outcomes and cost-effectiveness analysis of a cohort from CHEST.
    Taylor C; Thompson K; Finfer S; Higgins A; Jan S; Li Q; Liu B; Myburgh J;
    Lancet Respir Med; 2016 Oct; 4(10):818-825. PubMed ID: 27324967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of hemorrhage related to cardiothoracic operations.
    Herwaldt LA; Swartzendruber SK; Edmond MB; Embrey RP; Wilkerson KR; Wenzel RP; Perl TM
    Infect Control Hosp Epidemiol; 1998 Jan; 19(1):9-16. PubMed ID: 9475343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Decision of the European Medicines Agency on hydroxyethyl starch : Important step towards therapeutic and legal security].
    Zwissler B; Rossaint R
    Anaesthesist; 2013 Nov; 62(11):869-70. PubMed ID: 24275932
    [No Abstract]   [Full Text] [Related]  

  • 15. Presurgical hyper-volaemic haemodilution for saving blood transfusion?
    Gille J; Winter V; Sablotzki A; Wiedemann B; Richter A; Serfas R
    Eur J Anaesthesiol; 2008 Feb; 25(2):172-3. PubMed ID: 18251041
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxyethyl starch: putting patient safety first.
    Bion J; Bellomo R; Myburgh J; Perner A; Reinhart K; Finfer S
    Intensive Care Med; 2014 Feb; 40(2):256-259. PubMed ID: 24352482
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravascular volume therapy with colloids in cardiac surgery.
    Lange M; Ertmer C; Van Aken H; Westphal M
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):847-55. PubMed ID: 20709570
    [No Abstract]   [Full Text] [Related]  

  • 18. Does hydroxyethyl starch increase blood loss in cardiac operations.
    Durand M; Chavanon O
    Ann Thorac Surg; 2003 May; 75(5):1682-3; author reply 1683. PubMed ID: 12735616
    [No Abstract]   [Full Text] [Related]  

  • 19. EMA recommendation to suspend HES is hazardous.
    Annane D; Fuchs-Buder T; Zoellner C; Kaukonen M; Scheeren TWL
    Lancet; 2018 Feb; 391(10122):736-738. PubMed ID: 29449011
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyethyl starch 130/0.4: safe for the kidney in surgical patients?
    Wiedermann CJ
    Anesthesiology; 2013 Sep; 119(3):735-6. PubMed ID: 23962943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.